Yomeishu Seizo Co., Ltd. (2540) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Pharma Foods International Co., Ltd.

CB GROUP MANAGEMENT Co., Ltd.

Kissei Pharmaceutical Co., Ltd.

Astena Holdings Co., Ltd.

NANO MRNA Co., Ltd.

O'will Corp.

Morishita Jintan Co., Ltd.

euglena Co., Ltd.

Yomeishu Seizo Co., Ltd.

Ohki Health Care Holdings, Inc.

CellSeed, Inc.

Why is Yomeishu Seizo Co., Ltd. ?

Poor Management Efficiency with a low ROE of 2.04%

The company has been able to generate a Return on Equity (avg) of 2.04% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of -1.96% over the last 5 years

Flat results in Dec 25

NET SALES(Q) Fallen at -12.18%
OPERATING PROFIT(Q) Lowest at JPY 208.08 MM
OPERATING PROFIT MARGIN(Q) Lowest at 7.86 %

Underperformed the market in the last 1 year

The stock has generated a return of 29.37% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 85.83%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Yomeishu Seizo Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Yomeishu Seizo Co., Ltd.

29.37%

2.12

37.80%

Japan Nikkei 225

85.83%

3.09

27.80%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.96%

EBIT Growth (5y)

-28.78%

EBIT to Interest (avg)

45.05

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

0.22

Tax Ratio

30.22%

Dividend Payout Ratio

91.69%

Pledged Shares

Institutional Holding

ROCE (avg)

1.90%

ROE (avg)

2.04%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.36

EV to EBIT

371.90

EV to EBITDA

58.50

EV to Capital Employed

1.44

EV to Sales

6.06

PEG Ratio

8.59

Dividend Yield

ROCE (Latest)

0.39%

ROE (Latest)

1.70%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

No Trend

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at -17.03 %

-3What is not working for the Company

NET SALES(Q)

Fallen at -12.18%

OPERATING PROFIT(Q)

Lowest at JPY 208.08 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 7.86 %

Here's what is working for Yomeishu Seizo Co., Ltd.

Debt-Equity Ratio

Lowest at -17.03 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Yomeishu Seizo Co., Ltd.

Net Sales

Fallen at -12.18%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (JPY MM)

Operating Profit

Lowest at JPY 208.08 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (JPY MM)

Operating Profit Margin

Lowest at 7.86 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales